APPLIED THERAPEUTICS INC. - COMMON STOCK

Applied Therapeutics Receives Orphan Medicinal Product Designation from the EMA for AT-007 for Treatment of Galactosemia

03 6月 2022 07:00:00 条件 Nasdaq GlobeNewswire

Applied Therapeutics to Present at the UBS Global Healthcare Conference

19 5月 2022 07:00:00 条件 Nasdaq GlobeNewswire

Applied Therapeutics Reports First Quarter 2022 Financial Results

12 5月 2022 06:59:25 条件 Nasdaq GlobeNewswire

Applied Therapeutics to Present Data on AT-007 Treatment in SORD Deficiency at the 2022 Annual Meeting of the Peripheral Nerve Society

05 5月 2022 07:30:00 条件 Nasdaq GlobeNewswire

Applied Therapeutics to Present at the 43rd Annual Meeting of the Society for Inherited Metabolic Disorders

04 4月 2022 07:30:00 条件 Nasdaq GlobeNewswire

Applied Therapeutics to Present at the 2022 Annual Clinical Genetics Meeting of the American College of Molecular Genetics and Genomics

16 3月 2022 07:30:00 条件 Nasdaq GlobeNewswire

Applied Therapeutics Reports Fourth Quarter and Year-end 2021 Financial Results

10 3月 2022 07:30:01 条件 Nasdaq GlobeNewswire

Applied Therapeutics to Present at the Cowen and Barclays Investor Conferences

01 3月 2022 07:00:02 条件 Nasdaq GlobeNewswire

Applied Therapeutics Supports 15th Annual Rare Disease Day

28 2月 2022 07:30:00 条件 Nasdaq GlobeNewswire

Applied Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference

10 2月 2022 07:00:00 条件 Nasdaq GlobeNewswire

Applied Therapeutics Provides Regulatory Update on Galactosemia Program

03 1月 2022 07:00:00 条件 Nasdaq GlobeNewswire

Applied Therapeutics Announces Initiation of Registrational Phase 2/3 Study of AT-007 in SORD Deficiency

16 12月 2021 07:00:00 条件 Nasdaq GlobeNewswire

Applied Therapeutics to Present at the 14th International Congress of Inborn Errors of Metabolism

18 11月 2021 07:00:02 条件 Nasdaq GlobeNewswire

Applied Therapeutics Reports Biomarker Data from Pilot Trial of AT-007 in SORD Deficiency

25 10月 2021 07:00:00 条件 Nasdaq GlobeNewswire

Applied Therapeutics Reports Additional Pediatric Biomarker Data from ACTION-Galactosemia Kids

18 10月 2021 07:00:01 条件 Nasdaq GlobeNewswire

Applied Therapeutics Reports Initial Pediatric Biomarker Data from ACTION-Galactosemia Kids

09 9月 2021 07:00:01 条件 Nasdaq GlobeNewswire

Applied Therapeutics Reports Second Quarter 2021 Financial Results

12 8月 2021 07:00:02 条件 Nasdaq GlobeNewswire

Applied Therapeutics Added to Russell Microcap® Index

28 6月 2021 07:00:00 条件 Nasdaq GlobeNewswire

Applied Therapeutics Announces Presentation of Data on the Prevalence of Diabetic Cardiomyopathy at the 81st Scientific Sessions of the 2021 Annual Meeting of the American Diabetes Association

25 6月 2021 12:05:54 条件 Nasdaq GlobeNewswire

Applied Therapeutics to Present on Diabetic Cardiomyopathy and Prevalence of Disease at the 81st Scientific Sessions of the 2021 Annual Meeting of the American Diabetes Association

21 6月 2021 07:00:00 条件 Nasdaq GlobeNewswire